The Calendar Week — Pharmaceutical Fellowship Ceo Says He Has A 'Moral Requirement' To Sell Drugs At The Highest Price

Because "shareholder value."

[Nirmal Mulye, principal executive of Nostrum Laboratories,] told FT he agreed amongst Martin "Pharma Bro" Shkreli raising the toll of AIDS as well as cancer drug Daraprim inwards 2015 from $13.50 to $750 per tablet, maxim he was "within his rights because he had to vantage his shareholders."

We alive inwards a "capitalist economic scheme as well as if y'all can't brand coin y'all can't remain inwards business," Mulye said. "We convey to brand coin when nosotros can.

Appropriately, nirman agency "no mind."

The Week

Pharmaceutical society CEO says he has a 'moral requirement' to sell drugs at the highest price

Catherine Garcia